MDLN · Nasdaq · CIK 0002046386

Medline Inc.

Medline Inc.’s most recent SEC filing in our snapshot is a Form 8-K filed on Oct 21, 2026. In fiscal 2025 (year ended Dec 31, 2025) it reported revenue of $28.4B and net income of $1.2B, according to its XBRL data on EDGAR. Its EDGAR record lists 65 Form 4 insider filings from the 12 months before our last refresh.

SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.

Revenue, FY2025
$28.4B
Net income, FY2025
$1.2B
Form 4 filings on record, past 12 months
65

Company overview

Legal name (as filed)
Medline Inc.
Ticker
MDLN
SEC Central Index Key (CIK)
0002046386
Business address
NORTHFIELD, IL
State or country of incorporation
DE
Fiscal year ends
December 31
SEC filer category
Non-accelerated filer
Position in SEC ticker list
#336 of the 3,000 companies we track

Five-year financial highlights

Full-year figures from Medline Inc.’s annual reports, as tagged in XBRL and published by the SEC. Amounts are in U.S. dollars; the fiscal year is named for the calendar year in which it ends.

Revenue
$23.2BFY2023$25.5BFY2024$28.4BFY2025
Net income
$234.0MFY2023$1.2BFY2024$1.2BFY2025
MDLN annual results
ItemFY2023
ended Dec 31, 2023		FY2024
ended Dec 31, 2024		FY2025
ended Dec 31, 2025
Revenue$23.2B$25.5B$28.4B
Net income$234.0M$1.2B$1.2B
Diluted EPS——-$0.01
Total assets—$36.0B$38.5B
Cash and equivalents$1.6B$199.0M$1.9B

XBRL tags used: revenue = Revenues; netIncome = ProfitLoss; assets = Assets; eps = EarningsPerShareDiluted; cash = CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents. EPS is shown as originally reported for each year and may not be adjusted for later stock splits. A dash means the company did not report that item in a form we could match.

How to read these numbers

Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.

Latest key reports

The most recent filing of each major report type, even if it falls outside the 40 newest filings below.

MDLN latest annual, quarterly, current and proxy reports
FiledFormWhat it isOriginal
Feb 25, 202610-KAnnual report· period Dec 31, 2025Document · Index
Aug 5, 202610-QQuarterly report· period Jun 27, 2026Document · Index
Oct 21, 20268-KRegulation FD disclosure· period Oct 21, 2026Document · Index
Apr 23, 2026DEF 14ADefinitive proxy statement· period Jun 11, 2026Document · Index

Recent SEC filings

The 40 newest documents filed by or about Medline Inc., by form type:

4 ×278-K ×6SCHEDULE 13G/A ×2144 ×1SCHEDULE 13G ×110-Q ×1424B4 ×1EFFECT ×1
MDLN recent filings
FiledFormWhat it isOriginal
Oct 21, 20268-KRegulation FD disclosure· period Oct 21, 2026Document · Index
Oct 15, 20268-KDirector or officer change· period Oct 13, 2026Document · Index
Oct 13, 20264Statement of changes in beneficial ownership (insider trade)· period Oct 8, 2026Document · Index
Oct 6, 20264Statement of changes in beneficial ownership (insider trade)· period Oct 2, 2026Document · Index
Aug 21, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 19, 2026Document · Index
Aug 21, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 19, 2026Document · Index
Aug 17, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 13, 2026Document · Index
Aug 11, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index
Aug 11, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 7, 2026Document · Index
Aug 7, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index
Aug 7, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 5, 2026Document · Index
Aug 7, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 6, 2026Document · Index
Aug 6, 2026SCHEDULE 13GPassive beneficial ownership report (over 5%)Document · Index
Aug 5, 202610-QQuarterly report· period Jun 27, 2026Document · Index
Aug 5, 20268-KResults of operations· period Aug 5, 2026Document · Index
Jul 9, 20268-KDirector or officer change· period Jul 7, 2026Document · Index
Jun 17, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 15, 2026Document · Index
Jun 17, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 15, 2026Document · Index
Jun 17, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 15, 2026Document · Index
Jun 17, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 15, 2026Document · Index
Jun 17, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 15, 2026Document · Index
Jun 17, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 15, 2026Document · Index
Jun 17, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 15, 2026Document · Index
Jun 17, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 15, 2026Document · Index
Jun 16, 2026144Notice of proposed sale of securitiesDocument · Index
Jun 15, 20264Statement of changes in beneficial ownership (insider trade)· period Dec 16, 2025Document · Index
Jun 15, 20264Statement of changes in beneficial ownership (insider trade)· period Dec 16, 2025Document · Index
Jun 15, 20264Statement of changes in beneficial ownership (insider trade)· period Dec 16, 2025Document · Index
Jun 12, 20268-KShareholder vote results· period Jun 11, 2026Document · Index
Jun 9, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 5, 2026Document · Index
Jun 2, 20268-KMaterial agreement; New financial obligation; Other events· period May 28, 2026Document · Index
Jun 1, 20264Statement of changes in beneficial ownership (insider trade)· period May 28, 2026Document · Index
Jun 1, 20264Statement of changes in beneficial ownership (insider trade)· period May 28, 2026Document · Index
Jun 1, 20264Statement of changes in beneficial ownership (insider trade)· period May 28, 2026Document · Index
Jun 1, 20264Statement of changes in beneficial ownership (insider trade)· period May 28, 2026Document · Index
May 26, 20264Statement of changes in beneficial ownership (insider trade)· period May 21, 2026Document · Index
May 26, 20264Statement of changes in beneficial ownership (insider trade)· period May 21, 2026Document · Index
May 26, 2026424B4424B4Document · Index
May 26, 20264Statement of changes in beneficial ownership (insider trade)· period May 21, 2026Document · Index
May 21, 2026EFFECTEFFECTDocument · Index

Insider filing activity

65 Form 4 filings appear in Medline Inc.’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.

Other companies in Surgical & Medical Instruments & Apparatus

All 51 companies in Surgical & Medical Instruments & Apparatus· Companies headquartered in Illinois

On Amazon

Popular tools for investors

As an Amazon Associate I earn from qualifying purchases.

Electronics Plaud Note Pro AI Voice Recorder An AI voice recorder that turns earnings calls and meetings into notes. View on Amazon → Electronics Amazon Kindle Paperwhite Signature Edition 32GB Read investing classics and long reports without eye strain. View on Amazon → Electronics Apple 2026 MacBook Air 13-inch Laptop A lightweight laptop for spreadsheets and filing research. View on Amazon →

Source

  • U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0002046386 and XBRL company facts. Medline Inc. on EDGAR.
  • Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.

Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.